Showing results (71-80 of 518) with videos related to
Sort By:
Pageof 52
Cancers|July 24, 2021
Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176Edouard Auclin, Laura Mezquita, Benjamin BesseChinese Clinical Oncology|January 6, 2016
Methodology of clinical trials in lung cancerJessica Menis, Benjamin Besse, Denis LacombeCancer Cell|January 18, 2020
One or Two Immune Checkpoint Inhibitors?Caroline Robert, Emilie Lanoy, Benjamin BesseCancer Treatment Reviews|June 26, 2021
Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challengesKaushal Parikh, Lizza E L Hendriks, Paolo Bironzo, et al.Presse Medicale (Paris, France : 1983)|March 23, 2011
[Lung cancer in never smoker: Epidemiology, molecular profiles and treatment]Julien Hadoux, Benjamin Besse, David PlanchardJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2018
Progress in the Management of Advanced Thoracic Malignancies in 2017Roberto Ferrara, Laura Mezquita, Benjamin BesseBulletin Du Cancer|November 8, 2012
[Thymic epithelial neoplasms: updates on diagnosis, staging, biology and management in France]Julien Hadoux, Nicolas Girard, Benjamin BesseJAMA Oncology|April 9, 2026
Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received PembrolizumabAdrien Rousseau, Stéphanie Foulon, David Planchard, et al.Bulletin Du Cancer|December 6, 2006
[Neoadjuvant chemotherapy in non small cell lung cancer]Benjamin Besse, Stéphane Vignot, Thierry Le ChevalierTranslational Lung Cancer Research|December 4, 2018
Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapyLizza E Hendriks, Etienne Rouleau, Benjamin BessePageof 52